RITONAVIR — all Canadian products
8 DINs
4 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is RITONAVIR, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02523620 | AURO-RITONAVIR | AURO PHARMA INC | Tablet | Oral | RITONAVIR 100 MG | Marketed | |
| 02285533 | KALETRA | ABBVIE CORPORATION | Tablet | Oral | RITONAVIR 50 MG; LOPINAVIR 200 MG | Marketed | |
| 02357593 | NORVIR | ABBVIE CORPORATION | Tablet | Oral | RITONAVIR 100 MG | Marketed | |
| 02524031 | PAXLOVID | PFIZER CANADA ULC | Tablet | Oral | RITONAVIR 100 MG; NIRMATRELVIR 150 MG | Marketed | |
| 02229145 | NORVIR | ABBVIE CORPORATION | Solution | Oral | RITONAVIR 80 MG | Cancelled Post Market | |
| 02229137 | NORVIR | ABBVIE CORPORATION | Capsule | Oral | RITONAVIR 100 MG | Cancelled Post Market | |
| 02241480 | NORVIR SEC | ABBVIE CORPORATION | Capsule | Oral | RITONAVIR 100 MG | Cancelled Post Market | |
| 02527804 | PAXLOVID | PFIZER CANADA ULC | Tablet | Oral | RITONAVIR 100 MG; NIRMATRELVIR 150 MG | Cancelled Post Market |
Browse other molecules: